|
Mechanism11β-HSD1 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date19 Aug 1965 |
100 Clinical Results associated with Mayado Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Mayado Pharmaceutical Co., Ltd.
100 Deals associated with Mayado Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Mayado Pharmaceutical Co., Ltd.